WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, April 11, 2007, 27(15):4165-4177; doi:10.1523/JNEUROSCI.5648-06.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tappe-Theodor, A.
Right arrow Articles by Kuner, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tappe-Theodor, A.
Right arrow Articles by Kuner, R.

 Previous Article  |  Next Article 

Cellular/Molecular
A Molecular Basis of Analgesic Tolerance to Cannabinoids

Anke Tappe-Theodor,1 * Nitin Agarwal,1 * István Katona,2 Tiziana Rubino,3 Lene Martini,4 Jakub Swiercz,1 Ken Mackie,5 Hannah Monyer,6 Daniela Parolaro,3 Jennifer Whistler,4 Thomas Kuner,7 and Rohini Kuner1

1Pharmacology Institute, University of Heidelberg, 69120 Heidelberg, Germany, 2Institute of Experimental Medicine, Hungarian Academy of Sciences, 1083 Budapest, Hungary, 3Department of Structural and Functional Biology, Pharmacology Section and Neuroscience Center, University of Insubria, 21100 Busto Arsizio, Varese, Italy, 4Ernest Gallo Clinic and Research Center, University of California, San Francisco, San Francisco, California 94608, 5Department of Anesthesiology, University of Washington School of Medicine, Seattle, Washington 98195-6540, 6Department of Clinical Neurobiology, Interdisciplinary Center for Neuroscience, 69120 Heidelberg, Germany, and 7Max Planck Institute for Medical Research, 69120 Heidelberg, Germany

Correspondence should be addressed to Rohini Kuner, Pharmacology Institute, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany. Email: rohini.kuner{at}pharma.uni-heidelberg.de

Clinical usage of cannabinoids in chronic pain states is limited by their central side effects and the pharmacodynamic tolerance that sets in after repeated dosage. Analgesic tolerance to cannabinoids in vivo could be caused by agonist-induced downregulation and intracellular trafficking of cannabinoid receptors, but little is known about the molecular mechanisms involved. We show here that the type 1 cannabinoid receptor (CB1) interacts physically with G-protein-associated sorting protein 1 (GASP1), a protein that sorts receptors in lysosomal compartments destined for degradation. CB1–GASP1 interaction was observed to be required for agonist-induced downregulation of CB1 in spinal neurons ex vivo as well as in vivo. Importantly, uncoupling CB1 from GASP1 in mice in vivo abrogated tolerance toward cannabinoid-induced analgesia. These results suggest that GASP1 is a key regulator of the fate of CB1 after agonist exposure in the nervous system and critically determines analgesic tolerance to cannabinoids.

Key words: cannabinoid receptor 1; receptor trafficking; protein–protein interactions; endocytosis; GASP; spinal nociception


Received Oct. 18, 2006; revised Feb. 1, 2007; accepted Feb. 5, 2007.

Correspondence should be addressed to Rohini Kuner, Pharmacology Institute, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany. Email: rohini.kuner{at}pharma.uni-heidelberg.de




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. L. McKinney, M. P. Cassidy, L. M. Collier, B. R. Martin, J. L. Wiley, D. E. Selley, and L. J. Sim-Selley
Dose-Related Differences in the Regional Pattern of Cannabinoid Receptor Adaptation and in Vivo Tolerance Development to {Delta}9-Tetrahydrocannabinol
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 664 - 673.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Thompson, M. Pusch, and J. L. Whistler
Changes in G Protein-coupled Receptor Sorting Protein Affinity Regulate Postendocytic Targeting of G Protein-coupled Receptors
J. Biol. Chem., October 5, 2007; 282(40): 29178 - 29185.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-